Beneficient (NASDAQ: BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust ...
Anxiety and panic are complex responses, but the most effective way to cope with them is with simplistic, basic interventions ...
Simufilam advancing towards a clinical study expected to begin in H1 2026 for the potential treatment of TSC-related epilepsyFurther fortified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback